Target intelligence / Profile preview

Ribosomal protein L32 pseudogene 32 (RPL32P32)

Target
RPL32P32
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L32 pseudogene 32 is a processed pseudogene locus in the human genome, related to the protein-coding gene ribosomal protein L32 (RPL32). Pseudogenes are genomic DNA sequences similar to protein-coding genes but typically lack the ability to encode functional proteins due to mutations, deletions, or lack of regulatory sequences[5][1][2][7]. RPL32P32 does not have proven biological function, disease association, or relevance as a therapeutic target. The designation is typical of automated genome annotation and does not correspond to a molecular entity with established canonical name, abbreviation, or mechanism of action. Summary: - The target "ribosomal protein L32 pseudogene 32 (RPL32P32)" is a non-functional pseudogene, not a receptor, enzyme, transporter, or disease-modifying target. - It is not recognized as a biologically active or druggable entity in current biomedical databases or literature. - The entry should be considered incorrect or invalid as a molecular target for drug discovery or therapeutic monitoring, unless new experimental evidence arises.

Other names
RPL32_10_1563RPL32P32
02

Mechanism of action

None known for RPL32P32.

03

Biological functions

No established biological function for RPL32P32 itself.
04

Disease associations

No direct disease association for RPL32P32.

Beyond the preview

Go deeper on Ribosomal protein L32 pseudogene 32 (RPL32P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L32 pseudogene 32 (RPL32P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call